Gene therapy approaches for heart and peripheral ischemic diseases.

Project Information

GENE THERAPY ISCHAEM

Grant agreement ID: QLK3-CT-1999-50734

Project closed

Start date 28 August 2000

End date 27 August 2004

Funded under

• Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Total cost € 96 000,00

EU contribution € 96 000,00

Coordinated by

AVENTIS PHARMA S.A.
France

Objective

Evaluation of therapeutic benefit of gene therapy treatments in animal models of chronic schema: - relevant animal models and clinical evaluation tools - different gene therapy approaches (gene transfer vectors; genes)

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques.

• medical and health sciences › medical biotechnology › genetic engineering › gene therapy

You need to log in or register to use this function

Programme(s)

• FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Topic(s)

• 1.1.1.-3. - Key action The "Cell factory"

Call for proposal

Data not available

Funding Scheme

BUR - Bursaries, grants, fellowships

Coordinator

AVENTIS PHARMA S.A.

• EU contribution: No data
• Address: Quai Jules Guesde, 13 ; 94403 VITRY SUR SEINE ; France
• Total cost: No data